COVID-19 vaccines may cause allergic reactions in 1 in 100,000 jabs

News
By published

These reactions are "exceedingly rare," officials said.

Vials of the Pfizer-BioNTech Covid-19 vaccine.
(Image credit: PATRICK T. FALLON/AFP via Getty Images)

Serious allergic reactions after  COVID-19 vaccines are likely more common than serious reactions following flu vaccines, but are still very rare, according to a new report.

The report authors, from the Centers for Disease Control and Prevention (CDC), analyzed data from the first 1.9 million doses of COVID-19 vaccine administered in the U.S. from Dec. 14 through Dec. 23. For most of this time, only the Pfizer-BioNTech COVID-19 vaccine was available in the U.S. 

The researchers identified 21 cases of people who experienced anaphylaxis — a potentially life-threatening allergic reaction — shortly after receiving the COVID-19 vaccine. 

That's a rate of about 11 cases of anaphylaxis per 1 million doses of vaccine administered. For comparison, the rate of anaphylaxis following flu vaccination is 1.3 cases per million people, Dr. Nancy Messonnier, director of the CDC's National Center for Immunization and Respiratory Diseases, said during a news conference on Wednesday (Jan. 6).

Even though the rate of anaphylaxis tied to COVID-19 vaccines is about 10 times higher than what's seen with flu vaccines, "it's still exceedingly rare," Messonnier said. Overall, the benefits of the vaccine outweigh the potential risks, she said.

Related: 7 strange signs you're having an allergic reaction

Exactly what's causing these reactions is unclear, and "tremendous efforts" are underway to better understand the cause, Messonnier said. One potential culprit is polyethylene glycol, an ingredient in both the Pfizer and Moderna vaccines, Live Science previously reported. 

However, having allergies doesn't necessarily put you at higher risk of reactions to COVID-19 vaccines. Allergies are common in the U.S., but serious reactions to the vaccines are not.

The CDC recommends that people with a history of reactions to vaccines or anaphylaxis due to any cause should be observed by health care staff for 30 minutes after they receive their COVID-19 shot. (In the report, patients experienced anaphylaxis on average about 13 minutes after their COVID-19 shot.)

The agency recommends that people not receive the Pfizer or Moderna vaccine if they have a known allergy to an ingredient in these vaccines, including polyethylene glycol; and people should not receive a second dose if they have a serious reaction to the first.

Originally published on Live Science.  

Rachael Rettner
Rachael Rettner
Contributor

Rachael is a Live Science contributor, and was a former channel editor and senior writer for Live Science between 2010 and 2022. She has a master's degree in journalism from New York University's Science, Health and Environmental Reporting Program. She also holds a B.S. in molecular biology and an M.S. in biology from the University of California, San Diego. Her work has appeared in Scienceline, The Washington Post and Scientific American.